Biologics are ramping up
Biologics are grabbing a larger share of drug development, according to Fitch Ratings. Food and Drug Administration approvals of biologic drugs represented 28% of all new drug approvals in the last 21 months, up from 17% over the 2010-13 period, Fitch revealed in its latest Global Pharmaceutical R&D Pipeline report. “Biologics will continue to take
